Hosted on MSN
Why Primoris (PRIM) Stock Is Trading Lower Today
Shares of infrastructure construction company Primoris (NYSE:PRIM) fell 3.1% in the afternoon session after Guggenheim downgraded the stock to Neutral from a Buy rating. The analyst noted that the ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results